Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase A as a Structure Surrogate-Reference-Cited by-同舟云学术

Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase A as a Structure Surrogate

Published:2018-01-30 Issue:6 Volume:19 Page:613-621
ISSN:1439-4227
Container-title:ChemBioChem
language:en
Short-container-title:ChemBioChem

Author:

Judge Russell A.¹,Vasudevan Anil¹,Scott Victoria E.¹,Simler Gricelda H.²,Pratt Steve D.¹,Namovic Marian T.¹,Putman C. Brent¹,Aguirre Ana¹,Stoll Vincent S.¹,Mamo Mulugeta¹³,Swann Steven I.¹⁴,Cassar Steven C.¹,Faltynek Connie R.¹,Kage Karen L.¹⁵,Boyce-Rustay Janel M.¹⁶,Hobson Adrian D.²^ORCID

Affiliation:

1. AbbVie, Inc.; 1 North Waukegan Road North Chicago IL 60064 USA

2. AbbVie Bioresearch Center; 100 Research Drive Worcester MA 01605 USA

3. Current address: Novartis Institute for Biomedical Research; 4560 Horton Street Emeryville CA 94608 USA

4. Current address: Takeda Pharmaceuticals; 10410 Science Center Drive San Diego CA 92121 USA

5. Current address: Altor Bioscience; 2810 North Commerce Parkway Miramar FL 33025 USA

6. Current address: Genentech; 1 DNA Way South San Francisco CA 94080 USA

Funder

AbbVie

Publisher

Wiley

Subject